Hidradenitis Suppurativa Clinical Trials

A listing of Hidradenitis Suppurativa medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 42 clinical trials
Featured trial
A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients with Neutrophilic Skin Diseases

A Multiple-Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY3041658 in Patients with Neutrophilic Skin Diseases

  • 574 views
  • 25 Mar, 2021
  • 1 location
A Study of Bermekimab for the Treatment of Participants With Moderate to Severe Hidradenitis Suppurativa (LYRA)

The purpose of this study is to evaluate the dose-response of bermekimab efficacy in participants with moderate to severe Hidradenitis Suppurativa (HS).

adalimumab
abscess
  • 170 views
  • 27 Jul, 2022
  • 44 locations
A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy

Hidradenitis suppurativa (HS) is a chronic and often painful inflammatory skin disease which includes the forming of lumps, abscesses and scars in areas of the skin such as under the breasts

abscess
  • 43 views
  • 28 Jul, 2022
  • 39 locations
Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources, for the Study of the Immune System and of Its Genetic and Environmental Determinants. (CoSImmGEn)

CoSImmGEn is a protocol set up to respond to the current lack of healthy and sick population cohorts. Biological resources from these cohorts allow researchers to study the immune system and its genetic and environmental determinants. Those cohorts and collections are open not only to the Pasteurian community but also …

Accepts healthy volunteers
  • 109 views
  • 29 May, 2022
  • 3 locations
Optimizing Intralesional Triamcinolone Dosing for Hidradenitis Suppurativa

Currently, there is limited evidence showing increased resolution of HS flares with higher doses of intralesional triamcinolone (ILTAC) as well as a difference in side effect profile between the doses. The goal of this study is to determine the efficacy of treating HS flares with ILTAC-10, ILTAC-20 and ILTAC-40 and …

Accepts healthy volunteers
abscess
triamcinolone
  • 0 views
  • 25 Mar, 2022
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment

Investigators hypothesize that ruxolitinib 1.5% cream is an effective therapy for HS participants through inhibition of inflammatory activity. Investigators aim to: Demonstrate the clinical efficacy of ruxolitinib 1.5% cream in decreasing the clinical disease activity after 16 weeks of treatment. Investigate the impact of ruxolitinib 1.5% cream on skin inflammation …

antibiotics
retinoids
tuberculosis
il-17
spironolactone
  • 0 views
  • 12 Aug, 2022
  • 1 location
Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa

Hidradenitis suppurativa (HS) is a common chronic skin disease where patients experience inflamed painful nodules and chronic suppurating tunnels under the skin that often leave mutilating scars

anxiety
dmsc
purulent discharge
  • 19 views
  • 09 Aug, 2021
  • 1 location
Hidradenitis Suppurativa Phase 2b Pivotal Study of Izokibep

Izokibep is a potent and selective inhibitor of interleukin 17A (IL-17A) that is being developed for treatment of hidradenitis suppurativa (HS). This study will evaluate the efficacy

interleukin
antibiotics
antiseptics
abscess
  • 26 views
  • 11 Jul, 2022
  • 15 locations
A Study to Evaluate RIST4721 in Hidradenitis Suppurativa (HS)

A Randomized, Double-blinded, Placebo-controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects with Hidradenitis Suppurativa

  • 0 views
  • 23 Jul, 2022
  • 3 locations
ATI-450 vs Placebo in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

This is a Phase 2a study to investigate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of ATI-450 vs placebo in patients with moderate to severe Hidradenitis

  • 0 views
  • 14 Mar, 2022
  • 3 locations